RxDoctor Payments Data

Joshua Cohen, MD

Cardiovascular Disease · Norfolk, VANPI 1942658570

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Abbott accounts for 79.6% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $78,231, more than ten times the $53 reported in 2023. Among cardiovascular disease clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,417in general payments, 2019–2025

Across 62 payments — averaging $1264.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$62K
  • Medtronic$14K
  • Edwards Lifesciences$2K
  • Jenavalve Technology, Inc.$280
  • Abiomed$37
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$32
  • plus $17 from 1 others
$2,693in research payments, 2019–2025

Across 24 payments — averaging $112.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$3K

What the payments were for

  • Consulting fees$35,42545%
  • Speaking & faculty fees$13,77018%
  • Travel & lodging$27,60335%
  • Food & beverage$1,6192%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,417 in reported general payments places this provider in the 95th percentile of 548 cardiovascular disease providers in Virginia.

See all cardiovascular disease providers in Virginia

Medicare billing

Part B allowed, 2024
$54,476
Medicare patients
306
Services billed
751

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →